| Dr Kyle Steven Theriault, PHARMD | |
|
158 Cherry St, Burlington, VT 05401-3818 | |
| (802) 862-1562 | |
| Not Available |
| Full Name | Dr Kyle Steven Theriault |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 158 Cherry St, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699224691 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0121638 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Steven Theriault, PHARMD 158 Cherry St, Burlington, VT 05401-3818 Ph: (802) 862-1562 | Dr Kyle Steven Theriault, PHARMD 158 Cherry St, Burlington, VT 05401-3818 Ph: (802) 862-1562 |
News Archive
Traumatized children and children who develop multiple allergies tend to suffer in adulthood from chronic inflammatory diseases and psychiatric disorders.
Researchers at the University of Kansas Medical Center will use a $1.5 million grant from the National Cancer Institute to examine ways to lower the rates of cervical cancer among incarcerated women.
International Stem Cell Corporation, www.intlstemcell.com, today announced significant progress on its international development strategy for stem cell-derived human corneal tissue. Such tissue can potentially be used to replace cadaver-derived corneas in treatment of severe corneal vision impairment and to eliminate the need to use live animals in safety testing of drugs, chemicals and consumer products.
Merck, known as MSD outside the United States and Canada, and Intercell AG (VSE: ICLL) today announced that following a detailed analysis of the data from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus (S. aureus) infection, the independent Data Monitoring Committee (DMC) has unanimously recommended termination of the study.
Researchers from Yale University and Mirna Therapeutics, Inc., reversed the growth of lung tumors in mice using a naturally occurring tumor suppressor microRNA. The study reveals that a tiny bit of RNA may one day play a big role in cancer treatment, and provides hope for future patients battling one of the most prevalent and difficult to treat cancers.
› Verified 2 days ago
Daeun Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 514 Farrell St, Burlington, VT 05401 Phone: 802-651-0597 | |
Dr. Kyle Maxwell, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 158 Cherry St, Burlington, VT 05401 Phone: 802-862-1562 | |
Lea Juzek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 570 Shelburne Rd, Burlington, VT 05401 Phone: 802-860-3311 Fax: 802-860-2980 | |
Alan Mccampbell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1127 North Ave Ste 11, Burlington, VT 05408 Phone: 802-862-7752 | |
Hae Ji Yoon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 308 Shelburne Rd, Burlington, VT 05401 Phone: 802-864-8154 | |
Dr. Sarah Abdalla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35 Church St, Burlington, VT 05401 Phone: 803-651-1018 | |
Debra M Gibbs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Suite 1413, Burlington, VT 05401 Phone: 802-847-5519 Fax: 802-847-1076 |